noom vs hers glp 1 Med (2025): Which Online Weight Loss Is Better? Lilly cuts partnership with Noom
Description
The search strategy incorporated terms related to GLP-1 receptor agonists (e.g., GLP-1, Semaglutide, Liraglutide, Exenatide) in combination with alcohol use concepts (e.g., alcohol, alcohol use disorder, binge drinking, ethanol)

The GLP-1 Receptor Agonists Market is witnessing growth because of the increasing incidences of Type 2 Diabetes and obesity, the rising need for efficacious weight management solutions, cardioprotective effects, expansion in the areas of clinical use, high acceptance rates of medicines such as Semaglutide, and innovations in the pharma industry
doi: 10.1016/j.diabres.2022.110233

In monotherapy SGLT2 inhibitors have a low risk of causing hypoglycemia but in combinations with insulin or sulfonylureas may potentiate the development of hypoglycemia (22)
Autophagy in metabolic disease and ageing

GLP-1RAs may enhance fertility and manage polycystic ovary syndrome
